Unlike NEAT1 which has both oncogenic and tumor suppressor roles, MEG3 has been well reported to inhibit tumor growth in a p53‐dependant manner and this role is conserved in the case of AML (Zhou et al., 2012). Here, TP53 is linked to acute myeloid leukemia.